Protective mechanisms by glial cell line-derived neurotrophic factor and cerebral dopamine neurotrophic factor against the &#945;-synuclein accumulation in Parkinson's disease.

Er, Safak; Airavaara, Mikko

Protective mechanisms by glial cell line-derived neurotrophic factor and cerebral dopamine neurotrophic factor against the α-synuclein accumulation in Parkinson's disease.

Er, Safak; Airavaara, Mikko.

Er S; Faculty of Pharmacy, Drug Research Program, University of Helsinki, Helsinki, Finland.
Airavaara M; Faculty of Pharmacy, Drug Research Program, University of Helsinki, Helsinki, Finland.

Biochem Soc Trans ; 51(1): 245-257, 2023 02 27.

Article en En | MEDLINE | ID: mdl-36794783

Asunto(s)

Enfermedad de Parkinson; Sinucleinopatías; Animales; Ratones; Enfermedad de Parkinson/metabolismo; alfa-Sinucleína/metabolismo; Dopamina/metabolismo; Dopamina/farmacología; Dopamina/uso terapéutico; Sinucleinopatías/metabolismo; Sinucleinopatías/patología; Factor Neurotrófico Derivado de la Línea Celular Glial/metabolismo; Factor Neurotrófico Derivado de la Línea Celular Glial/farmacología; Neuronas Dopaminérgicas/metabolismo

Palabras clave

CDNF; GDNF; MANF; Parkinson's disease; neurodegeneration; neurotrophic factors

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Sinucleinopatías Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google